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ABSTRACT
Working towards the development of an evolvable cancer treatment simulator, the investigation of
Differential Evolution was considered, motivated by the high efficiency of variations of this technique
in real-valued problems. A basic DE algorithm, namely “DE/rand/1" was used to optimize the
simulated design of a targeted drug delivery system for tumor treatment on PhysiCell simulator. The
suggested approach proved to be more efficient than a standard genetic algorithm, which was not
able to escape local minima after a predefined number of generations. The key attribute of DE that
enables it to outperform standard EAs, is the fact that it keeps the diversity of the population high,
throughout all the generations. This work will be incorporated with ongoing research in a more wide
applicability platform that will design, develop and evaluate targeted drug delivery systems aiming
cancer tumours.
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1 Introduction
Differential evolution (DE) gained popularity over other well-established evolutionary algorithms (EAs), as it follows
similar algorithmic steps with standard EAs, but was able to surpass them in terms of efficiency [1]. There have been
several proposals on how to enhance its performance [2, 3] and these alternative algorithmic approaches, building on
the initial methodology, were tested in real problems , as well as numerical benchmark problems [4, 5, 6, 7].
DE was initially proposed in [1], as an effective methodology of optimization over continuous spaces of nonlinear and
non differentiable functions. The method was introduced as an alternative to previous direct search approaches, aiming
at three main objectives: the ability to find the global optimum, the fast convergence to this optimum and the need
of a small amount of control parameters for the procedure. Moreover, it was developed to be easily implemented in
parallel computing platforms. The methodology is population based, where for every generation the new individuals are
produced after applying the scaled difference (hence the name differential evolution) of some predefined individuals to
another predefined base individual.
The ability to easily extract attributes of the population, such as the distance of its members and their directions, through
the aforementioned methodology, is what makes DE so powerful. This characteristic is defined as self-referential
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mutation [8]. Given the aforementioned advantages of DE compared with other EAs, it was chosen to investigate the
optimization of a targeted drug delivery system (DDS) on a cancer tumour, when simulated with PhysiCell [9].
PhysiCell [9] is a multicellular, agent-based simulator that was designed to extend the BioFVM [10] framework, to
form a virtual laboratory. PhysiCell is open source and offers several sample projects, one of which is the one studied in
this study. More specifically, sample project “anti-cancer biorobots" [9] was developed as a possible tool to investigate
the targeted cancer treatment, i.e. with drugs transported by specialized nanoparticles that would target specific cells of
the cancer tumours.
Previously, PhysiCell was deployed as a virtual laboratory in the optimization process of the design of nanoparticle
carriers of cancer treating compounds [11, 12] and the process of mapping immunotherapies [13]. More specifically,
the use of PhysiCell led the training of surrogate-assisted evolutionary algorithms exploring the efficient solutions of the
design of nanoparticle-based drug delivery systems for cancer [11]. A similar application of PhysiCell was examined in
[12], where the optimization was achieved by a novel memetic algorithm inspired by the fundamental haploid-diploid
lifecycle of eukaryotic organisms [14, 15]. A similar application is considered here, however the exploration of the
solution space is investigated through DE. Moreover, active learning and genetic algorithms incorporated with the
PhysiCell simulator, enabled the efficient exploration of biological and clinical constraints for cancer immunotherapy
[13].
2 Differential evolution
The methodology of DE comprises of the following steps: initialization, mutation, recombination (or crossover) and
selection. At first, a population of individuals (possible solutions) is formed by randomly picking values on the
D-dimensional search space of the problem to be optimized. The random function used is mainly uniformly distributed
to cover sufficiently the search space, which could be limited with lower and upper boundaries depending on the
definition of the problem.
Then, the mutation operator is employed on the initial population. More specifically, for every individual in the
population a new individual is generated (named the mutant individual) by a mathematical expression of the parameters
of randomly chosen or predefined individuals. For example, the mutant individual (vi) can be the linear combination of
three randomly selected individuals as defined by the following equation, where xr1, xr2 and xr3 are randomly selected
individuals from the population and F is a scaling factor, which is a positive number.
vi = xr1 + F · (xr2 − xr3) (1)
Note here, that the variations of DE methodology are defined with a notation in the form of “DE/base/num". The “base"
part of the notation refers to the technique of choosing the individual that will be used as the base individual to which the
scaled difference will be added. The “num" part indicates the amount of pairs of individuals that will produce a scaled
difference each, to be added on the base individual. Thus, the aforementioned DE variation is denoted as “DE/rand/1".
The produced mutant individuals, then, undergo the crossover operator, in order to be recombined with individuals
from the initial population. Each individual chosen from the initial population is denoted as the target individual and
the produced individual after the crossover as the trial individual. Two crossover strategies are mainly used, namely
exponential and binomial. However, binomial is dominant in the literature, where every parameter in the D-dimensional
solution is treated separately to the others, and chosen from the mutant or the target individual based on a probability
defined as the CR parameter. This parameter is known as the crossover rate.
The final step of the algorithm is then evaluation, by the use of the selection operator. Similar to standard GAs, the trial
individuals produced from the previous step, are evaluated with the fitness function. If their fitness is better than the one
of their target individual, they replace the target individual in the next generation. Otherwise the target individual is
retained. When all trial individuals are tested and the appropriate selection is made to form the population of the next
generation, the algorithm runs again the population through the mutation, crossover and selection operators, until the
termination criteria are met (i.e. the computation budget).
3 Methodology
The sample project from PhysiCell framework that was investigated, is the “anti-cancer biorobots". In this simulation
all entities are simulated as agents. Namely, there are three different types of agents with different functionalities, the
cancer cells, the chemical compound (defined as cargo agents) and the functionalized nanoparticles (defined as worker
agents). The outputs of PhysiCell include graphical representation of the agents in the simulated areas. An example
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Current time: 3 days, 0 hours, and 0.01 minutes, z = 0.00 μm 
1112 agents 
200 μm 
0 days, 0 hours, 1 minutes, and 17.8120 seconds 
Figure 1: The graphical representation output of PhysiCell after 10 days of simulated growth and treatment of a cancer
tumour.
after 10 days of simulated growth and treatment of a tumour is depicted in Fig. 1. The cancer cells are illustrated as
green, the chemical compound as blue, while the nanoparticles as red agents.
The problem to be optimized here was defined as the design of nanoparticle agents in PhysiCell simulator (v.1.4.1)
that will result in lower number of remaining cancer cells. Each possible solution is mapped in a 6-dimensional space
where the parameters studied and their boundaries are the attached worker migration bias [0,1], the unattached worker
migration bias [0,1], worker relative adhesion [0,10], worker relative repulsion [0,10], worker motility persistence
time (min) [0,10] and the cargo release O2 threshold (mmHg) [0,20]. Due to the stochastic nature of the simulator
each possible solution is evaluated after extracting the average value of the remaining cancer cells of 5 runs. Each run
executes 7 days of growing an initial 200 micron radius tumor and 3 days of applying the treatment.
For comparison reasons, a generic GA was applied to optimize the aforementioned problem. The parameters of the
GA were chosen as population size P = 20, tournament size T = 2 for selection and replacement operations, uniform
crossover with probability X = 80% and per allele mutation rate of µ = 20% with random step size of s = [−5, 5]%.
On the other hand, the “DE/rand/1" strategy was implemented and tested for the optimization of a targeted DDS on
a cancer tumour, by simulating this procedure with PhysiCell. The parameters of the DE algorithm were chosen as
population size P = 20, scaling factor F = 0.5 and crossover rate CR = 0.9. Note that these parameters are not
fine-tuned to enhance the performance of the algorithm, but are most commonly used throughout the literature.
The rest of the parameters used to define the simulation of the tumour environment by PhysiCell were retained
unchanged. More specifically these parameters are listed in Table 1.
4 Results
Three comparison tests were run, each using the same initial population for the GA and DE optimization. The results
of the average fitness (remaining cancer cells after 10 days of simulation) of all individuals of the population through
out the generations are depicted in Figs. 2 - 4(a). Furthermore, the fitness of the best individual for both GA and DE
throughout the generations was illustrated in Figs. 2 - 4(b).
In Fig. 2(a) it is apparent that both approaches force the population to converge towards a lower fitness. However, in Fig.
2(b) the fact that DE outperforms the GA in finding better solutions from the first few generations is shown. Moreover,
the GA seems to be stuck from the sixth generation in a local minimum.
In Fig. 3(a) the GA approach seems to converge the average fitness of the population of solutions towards a lower
fitness faster than the DE. Also, in Fig. 3(b) the DE approach is outperformed by GA for the first six generations. On
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Table 1: Unaltered parameters of PhysiCell simulator.
Parameter Value
Damage rate 0.03333 min−1
Repair rate 0.004167 min−1
Drug death rate 0.004167 min−1
Elastic coefficient 0.05 min−1
Cargo O2 relative uptake 0.1 min−1
Cargo apoptosis rate 4.065e-5 min−1
Cargo relative adhesion 0
Cargo relative repulsion 5
Maximum relative cell adhesion distance 1.25
Maximum elastic displacement 50 µm
Maximum attachment distance 18 µm
Minimum attachment distance 14 µm
Motility shutdown detection threshold 0.001
Attachment receptor threshold 0.1
Worker migration speed 2 µm/min
Worker apoptosis rate 0 min−1
Worker O2 relative uptake 0.1 min−1
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Figure 2: Average (a) and best fitness (b) of the populations evolved with GA and DE in the first comparison run.
the contrary, the GA is again stuck in a local optimum, while the DE is continuously evolving towards better solutions
and manages to find a better one at the sixth generation.
Finally, the results from the third comparison run are presented in Fig. 4. As in the previous runs, it can be claimed that
DE outperforms the GA. Specifically, in Fig. 4(b) the DE approach reaches a fittest individual than GA at the very first
generations. Furthermore, whereas the DE seems to be stuck in a local minimum from the third generation and the GA
reaches a solution quite similar to this one, on the last generation the DE manages to escape its minimum and provide
an ever better solution.
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Figure 3: Average (a) and best fitness (b) of the populations evolved with GA and DE in the second comparison run.
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Figure 4: Average (a) and best fitness (b) of the populations evolved with GA and DE in the third comparison run.
The scatter plots of the parameters investigated during the evolution of DE in the third comparison run are outlined
in Fig. 5. It is clear that the individuals produced with the DE approach cover the search space better than the ones
produced by GA (illustrated in Fig. 6). This is attributed to the fact that DE is designed to tackle models defined in
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Figure 5: Scatter plot of all individuals tested during the DE approach for the third run. The red “X" mark denotes the
best individual found.
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Figure 6: Scatter plot of all individuals tested during the GA approach for the third run. The red “X" mark denotes the
best individual found.
real-values search spaces, whereas GA is not. As a result, the GA is heavily limited by the randomly produced initial
population, a disadvantage that is alleviated by the DE methodology.
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Figure 7: Scatter plot of the individuals in the final population for the DE approach for the third run. The red “X" mark
denotes the best individual found.
In addition, to clearly portray the reason why GA is easily trapped in local optima, while DE manages to escape them,
Figs. 7 and 8 are given, that present the final population of the DE and GA approaches for the third run, respectively.
The DE approach succeeds in maintaining a high diversity in the final population as shown in Fig. 7, where no duplicate
individuals can be spotted. On the other hand, in Fig. 8 the final population of the GA approach is apparently comprised
by multiple copies of just two individuals, which are also very close to each other. Consequently, the GA can not escape
from these two individuals unless a dramatic mutation happens (not possible as the mutation step size was set here to
s = [−5, 5]%).
5 Conclusion
The optimization of the design of targeted DDS on a cancer tumor, simulated by PhysiCell, was studied by utilizing
“DE/rand/1" approach. The DE approach was compared with a standard steady state GA with the same computation
budget, namely 1000 evaluations. The results derived from the comparison runs of both approaches equipped with the
same initial population unveiled that DE is a more robust algorithm to reach a better solution within the same amount of
generations. On top of that, DE enables the further exploration of the search space as it maintains a high diversity of the
individuals in the final population.
As an aspect of future work, different variations of DE can be investigated with PhysiCell and under alternative ultimate
goals, for instance the ability of niching is well documented in variants of DE [16]. Finally, the conclusions driven from
this study will be applied on ongoing research towards a more wide applicability platform that will design, develop and
evaluate DDSs aiming cancer tumours.
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Figure 8: Scatter plot of the individuals in the final population for the GA approach for the third run. The red “X" mark
denotes the best individual found.
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